Spectranetics to Acquire Stellarex™ Drug Coated Balloon Assets From Covidien...
(Source: Covidien plc) Spectranetics to Acquire Stellarex™ Drug Coated Balloon Assets From Covidien Conference Call Monday at 8:30 a.m. ET Expands Spectranetics' portfolio of solutions to treat complex...
View ArticleSpectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From...
(Source: The Spectranetics Corporation) Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien Conference Call Monday at 8:30 a.m. ET Expands Spectranetics' portfolio of...
View ArticleSpectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien
Conference Call Monday at 8:30 a.m. ET Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segment COLORADO SPRINGS, Colo.,...
View ArticleSpectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon...
COLORADO SPRINGS, Colo., Jan. 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced it has completed the acquisition of Covidien's Stellarex™ drug coated balloon...
View ArticleJury in Federal Court in California Finds Against AngioScore's Patent...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Sept. 30, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that a jury in the U.S. District Court...
View ArticleEXCITE ISR Landmark Study Proves Durability at 12-Months, Findings Validate...
(Source: The Spectranetics Corporation) EXCITE ISR Landmark Study Proves Durability at 12-Months, Findings Validate Safety and Superiority of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at...
View ArticleSpectranetics Appoints Todd C. Schermerhorn as Director (The Spectranetics...
(Source: The Spectranetics Corporation) Spectranetics Appoints Todd C. Schermerhorn as Director COLORADO SPRINGS, Colo., March 12, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC)...
View ArticleSpectranetics Announces Chief Financial Officer Transition
Guy Childs to Remain Officer of the Company COLORADO SPRINGS, Colo., March 18, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) reported today that Guy Childs, Chief Financial...
View ArticleFederal Court in California Awards AngioScore $20 Million Plus Disgorgement...
(Source: The Spectranetics Corporation) Federal Court in California Awards AngioScore $20 Million Plus Disgorgement in Breach of Fiduciary Duty Case COLORADO SPRINGS, Colo., July 2, 2015 (GLOBE...
View ArticleSpectranetics Appoints Todd C. Schermerhorn as Director
COLORADO SPRINGS, Colo., March 12, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its Board of Directors has appointed Todd C. Schermerhorn to the Board,...
View ArticleSpectranetics Announces Chief Financial Officer Transition (The Spectranetics...
(Source: The Spectranetics Corporation) Spectranetics Announces Chief Financial Officer Transition Guy Childs to Remain Officer of the Company COLORADO SPRINGS, Colo., March 18, 2015 (GLOBE NEWSWIRE)...
View ArticleSpectranetics Receives FDA 510(k) Clearance for Larger Diameter...
(Source: The Spectranetics Corporation) Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt(R) Scoring Balloon Enabling Entry Into New Markets Unlocks niche in endovascular care...
View ArticleSpectranetics Receives FDA 510(k) Clearance for Larger Diameter...
Unlocks niche in endovascular care with $150M market opportunity; Enables physicians to deliver precision, power, safety for hemodialysis fistula or graft COLORADO SPRINGS, Colo., June 24, 2015 (GLOBE...
View ArticleSpectranetics to Hold 2015 First Quarter Financial Results Conference Call on...
(Source: The Spectranetics Corporation) Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 COLORADO SPRINGS, Colo., April 13, 2015 (GLOBE NEWSWIRE) -- The...
View ArticleSpectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon...
(Source: The Spectranetics Corporation) Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of Below the Knee (BTK) Peripheral Vascular Disease BTK Market...
View ArticleSpectranetics' Stellarex(TM) Drug-coated Balloon Clinical Findings Published...
(Source: The Spectranetics Corporation) COMPANY CONTACT Karol Norie Sr. Marketing Communications Manager (719) 447-2463 For Immediate Release Spectranetics' Stellarex™ Drug-coated Balloon Clinical...
View ArticleSpectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy...
(Source: The Spectranetics Corporation) Turbo-Power(TM) is Backed by Level 1 Clinical Data Proving Clinical Superiority, Maximal Luminal Gain; Drives Next-Generation Standard of Care in ISR $350M...
View ArticleFirst Randomized Trial of the Stellarex™ Drug-coated Balloon Presented at the...
COLORADO SPRINGS, Colo., Aug. 10, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Professor Marianne Brodmann of Medical University Graz, Austria, presented...
View ArticleStellarex™ ILLUMENATE Pivotal Results Are Top-tier in the Most Complex...
COLORADO SPRINGS, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Dr. Sean Lyden presented the final 12-month results of the Stellarex...
View ArticleSpectranetics Files PMA Application for FDA Approval of the Stellarex™...
COLORADO SPRINGS, Colo., Nov. 02, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) announced today that it has submitted to the Food & Drug Administration (FDA) its Pre-Market...
View ArticleSpectranetics Receives CE Mark for Stellarex™ 0.014” Drug-Coated Balloon
COLORADO SPRINGS, Colo., Nov. 21, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that its Stellarex™ 0.014” Drug-coated Angioplasty Balloon (DCB) has received the...
View ArticleSpectranetics Names Scott Hutton as General Manager, Vascular Intervention
COLORADO SPRINGS, Colo., Jan. 11, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), (“the Company”) today announced that Scott Hutton has been named General Manager, Vascular...
View ArticleILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance...
COLORADO SPRINGS, Colo., Jan. 24, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), (“the Company”) today announced that Professor Thomas Zeller presented the final 12-month results...
View ArticleSpectranetics Names Scott Hutton as General Manager, Vascular Intervention...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Jan. 11, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), ('the Company') today announced that Scott Hutton has...
View ArticleILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Jan. 24, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), ('the Company') today announced that Professor Thomas...
View ArticleSpectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for...
COLORADO SPRINGS, Colo., Dec. 8, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of...
View ArticleSpectranetics to Present at the Canaccord Genuity Growth Conference (The...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., July 29, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at...
View ArticleFederal Court in California Awards AngioScore $20 Million Plus Disgorgement...
COLORADO SPRINGS, Colo., July 2, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the U.S. District Court for the Northern District of California has ruled in...
View ArticleSpectranetics Announces Fourth Quarter 2016 Conference Call
COLORADO SPRINGS, Colo., Feb. 02, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), today announced that the Company will release fourth quarter 2016 financial results on Thursday,...
View ArticleSpectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
COLORADO SPRINGS, Colo., Feb. 23, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months and year ended December 31, 2016. Highlights...
View ArticleSpectranetics Announces Fourth Quarter 2016 Conference Call (The...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Feb. 02, 2017 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC), today announced that the Company will release fourth...
View ArticleSpectranetics Announces Debt Financing (The Spectranetics Corporation)
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Dec. 7, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) announced today that it has completed the refinancing of...
View ArticleSpectranetics Receives FDA 510(k) Clearance for Bridge(TM) Occlusion Balloon...
COLORADO SPRINGS, Colo., Feb. 08, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) clearance of...
View ArticleSpectranetics Names Stacy McMahan Chief Financial Officer
COLORADO SPRINGS, Colo., Aug. 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that Stacy McMahan has been named Chief Financial Officer, effective September 28,...
View ArticleSpectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Feb. 08, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA)...
View ArticleSpectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for...
(Source: The Spectranetics Corporation) Breakthrough Technology Designed for Safe Lead Removal and Procedural Control COLORADO SPRINGS, Colo., Dec. 8, 2015 (GLOBE NEWSWIRE) -- The Spectranetics...
View ArticleSpectranetics Names Stacy McMahan Chief Financial Officer (The Spectranetics...
(Source: The Spectranetics Corporation) Spectranetics Names Stacy McMahan Chief Financial Officer COLORADO SPRINGS, Colo., Aug. 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC)...
View ArticleSpectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million (The...
(Source: The Spectranetics Corporation) COLORADO SPRINGS, Colo., Oct. 22, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three and nine...
View ArticleSpectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million
COLORADO SPRINGS, Colo., Oct. 22, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three and nine months ended September 30, 2015....
View ArticleSpectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million (The...
(Source: The Spectranetics Corporation) Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million FDA Clearance of In-Stent Restenosis Indication Achieved; AngioScore Integration On Track 2014...
View ArticleSpectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
Expands Stellarex™ Program to Below the Knee Market Updates 2015 Outlook COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today reported financial...
View ArticleSpectranetics Outlines Growth Opportunities at Analyst & Investor Meeting
Provides 2015 Outlook COLORADO SPRINGS, Colo., Dec. 4, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) will provide an overview of several transformative growth drivers within its...
View ArticleSpectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million
Stellarex DCB Acquisition Closed and Stellarex Launched in Europe Updates 2015 Outlook COLORADO SPRINGS, Colo., Feb. 19, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today...
View ArticleSpectranetics Outlines Growth Opportunities at Analyst & Investor Meeting...
(Source: The Spectranetics Corporation) Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting Provides 2015 Outlook COLORADO SPRINGS, Colo., Dec. 4, 2014 (GLOBE NEWSWIRE) -- The...
View ArticleSpectranetics Achieves First Quarter 2015 Revenue of $57.4 Million (The...
(Source: The Spectranetics Corporation) Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million Expands Stellarex™ Program to Below the Knee Market Updates 2015 Outlook COLORADO SPRINGS,...
View ArticleSpectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess...
(Source: The Spectranetics Corporation) Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology 300 Patients...
View Article
